Labs / Assays & in vitro testing
Agada
Halifax, NS, Canada · agadabio.com
GLP
AGADA Biosciences is a contract research organization specializing in rare disease programs. It supports biotech, pharma, and research teams with preclinical, bioanalytical, clinical specimen management, and translational strategy services from its facility in Halifax, Nova Scotia.
They take quote requests by email.
What they offer
Clinical specimen management
Oversees tissue processing at clinical sites, manages frozen muscle biopsies, and maintains chain of custody across global shipment workflows.
Quality assessment and reporting
Identifies freezing artifacts and procedural inconsistencies and produces quality reports aligned to the context of use.
Bioanalytical method validation
Provides pre-validated, regulatory-compliant bioassays for rare disease biomarkers and trial readouts.
Assay development
Designs custom bioassays around anticipated clinical biomarker readouts and regulatory endpoints.
Validated bioassays (off-the-shelf)
Offers ready-to-deploy bioassays for rare disease programs including Duchenne and Becker muscular dystrophies.
Existing bioassays
Applies client protocols or tailored instructions to coordinate biomarker sample analysis with other vendors.
Preclinical services
Executes efficacy studies in validated mouse models and generates functional, histological, and biomarker data.
In vitro
Provides in vitro preclinical research support as part of its preclinical services offering.
In vivo
Provides in vivo preclinical research support as part of its preclinical services offering.
Translational strategy consulting
Advises on study objectives, biomarker endpoints, and regulatory alignment for rare disease development.
Study design
Supports study design decisions as part of translational strategy consulting and preclinical planning.
Regulatory guidance
Provides regulatory guidance to align programs with FDA and EMA expectations.
What they work on
- Modalities
- gene therapy
- Species and models
- mouse models, Duchenne, Becker, ALS
- Assays and studies
- bioassays, biomarker assays, Western blot, immunofluorescence, Luciferase Immunoprecipitation System (LIPS), digital droplet PCR, quantitative PCR
- Scale and capacity
- 20,000 sq. ft. facility
- Therapeutic areas
- rare diseases, Duchenne muscular dystrophy, Becker muscular dystrophy, ALS
- Turnaround
- two to four months
- What to send
- frozen muscle biopsies · serum samples · plasma samples · tissue samples
- Type
- CRO
- Sites
- Halifax, Nova Scotia, Canada · Halifax, Canada
- Quality
- GCP · GLP · GDPR · CITI certification (GCP, GLP and GDPR guidelines)
- Serves
- global
- Address
- 1498 Lower Water Street MP-1115 Halifax, Nova Scotia B3J 3R5
- Founded
- 2013
Similar labs. Bioneeds, Biotest Facility, Desentum, EyeCRO
Found in a contract services directory. Listing built from agadabio.com. Work here? Claim this listing.